A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents

NCT00518180 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1620

Enrollment

INDUSTRY

Sponsor class

Conditions

Meningococcal Meningitis
Human Papillomavirus Infection
Pertussis
Tetanus

Interventions

BIOLOGICAL: Novartis Meningococcal ACWY Conjugate Vaccine
BIOLOGICAL: Tdap Vaccine
BIOLOGICAL: Novartis Meningococcal ACWY Conjugate Vaccine

Sponsor

Novartis Vaccines